Abstract
The hypoxic environment of solid tumor causes the tumor cells survive and which could protect them from death by facilitating resistance to therapy. Here, we provide evidence that hypoxia can increase tumor cell viability and proliferation through an Egr-1-dependant pathway. Hypoxia protected the microtubules from disassembly, and Egr-1 was colocalized with microtubules in different cell cycle stages. Knockdown of Egr-1 with its siRNA overcame the protection effect of hypoxia and increased the sensitivity of tumor cells to vinblastine under hypoxic conditions. Our results suggest a novel approach for increasing the sensitivity of tumor cells to chemotherapeutics that target microtubule assembly.
2010 Wiley-Liss, Inc.
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Blotting, Western
-
Carcinoma, Hepatocellular / drug therapy*
-
Carcinoma, Hepatocellular / metabolism
-
Carcinoma, Hepatocellular / pathology
-
Cell Proliferation / drug effects
-
Early Growth Response Protein 1 / antagonists & inhibitors
-
Early Growth Response Protein 1 / genetics
-
Early Growth Response Protein 1 / metabolism*
-
Fluorescent Antibody Technique
-
Humans
-
Hypoxia / metabolism*
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / metabolism
-
Liver Neoplasms / pathology
-
Microtubules / metabolism*
-
RNA, Small Interfering / pharmacology
-
Tumor Cells, Cultured
-
Vinblastine / pharmacology*
Substances
-
Antineoplastic Agents
-
Early Growth Response Protein 1
-
RNA, Small Interfering
-
Vinblastine